Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis
Clinical trial NCT00489918 · COMPLETED
Trial details
- NCT number
- NCT00489918
- Sponsor
- Zosano Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2008-04-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.